title: Blood substitutes: possibilities with nanotechnology.
abstract: Nanotechnology deals with molecules in the nanometer (10(-9)) range and is currently being used successfully in the field of medicine. Nanotechnology has important implications in nearly all the branches of medicine and it has all the capabilities to revolutionize the vast field of medicine in future. Nanotechnological advancements have been used for the preparation of artificial hemoglobin. It is formed by assembling the hemoglobin molecules into a soluble complex. A recent approach includes the assembling of this artificial hemoglobin with enzymes such as catalase and superoxide dismutase into a nano-complex. This complex acts as an oxygen carrier as well as an antioxidant in conditions with ischemia-reperfusion injuries.
authors.affiliation: Department of Pathology, J.N. Medical College, Aligarh Muslim University, Aligarh, 202002 UP India.
authors.forename: Feroz
authors.initials: F
authors.lastname: Alam
authors.affiliation: All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Neha
authors.initials: N
authors.lastname: Yadav
authors.affiliation: Department of Pathology, J.N. Medical College, Aligarh Muslim University, Aligarh, 202002 UP India.
authors.forename: Murad
authors.initials: M
authors.lastname: Ahmad
authors.affiliation: Department of Pathology, J.N. Medical College, Aligarh Muslim University, Aligarh, 202002 UP India.
authors.forename: Mariyam
authors.initials: M
authors.lastname: Shadan
keywords: Artificial red cells; Blood substitutes; Nanotechnology; Polyhemoglobin
references.citation: Nat Biotechnol. 1998 Jul;16(7):667-71
references.pmid: 9661202
references.citation: Nature. 1967 Nov 4;216(5114):458-60
references.pmid: 6057248
references.citation: Biomaterials. 1998 Aug;19(16):1529-39
references.pmid: 9794531
references.citation: Exp Hematol. 1980 May;8(5):584-92
references.pmid: 7461058
references.citation: Blood Rev. 1999 Sep;13(3):171-84
references.pmid: 10527269
references.citation: J Am Coll Surg. 2002 Oct;195(4):445-52; discussion 452-5
references.pmid: 12375748
references.citation: Nature. 1969 Feb 15;221(5181):618-22
references.pmid: 5774935
references.citation: Artif Cells Blood Substit Immobil Biotechnol. 1996 May;24(3):169-83
references.pmid: 8773737
references.citation: J Pharmacol Exp Ther. 1999 Feb;288(2):665-70
references.pmid: 9918573
references.citation: J Bioeng. 1976 Nov;1(1):25-32
references.pmid: 1052520
references.citation: Eur J Biochem. 1982 Jan;121(2):325-8
references.pmid: 7060552
references.citation: J Mol Biol. 1981 Apr 25;147(4):559-82
references.pmid: 7277501
references.citation: Science. 1964 Oct 23;146(3643):524-5
references.pmid: 14190240
references.citation: Artif Cells Blood Substit Immobil Biotechnol. 2003 Aug;31(3):231-47
references.pmid: 12906306
references.citation: Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):889-93
references.pmid: 7994414
references.citation: ASAIO Trans. 1988 Jan-Mar;34(1):24-8
references.pmid: 2454127
references.citation: Artif Cells Blood Substit Immobil Biotechnol. 1994;22(2):295-313
references.pmid: 8087248
references.citation: Proc (Bayl Univ Med Cent). 2001 Apr;14(2):158-61
references.pmid: 16369608
references.citation: Vox Sang. 2006 Aug;91(2):102-10
references.pmid: 16907870
references.citation: Transfusion. 2002 Jul;42(7):812-8
references.pmid: 12375651
references.citation: Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):183-202
references.pmid: 1391434
references.citation: Biochem Biophys Res Commun. 1971 Sep 17;44(6):1531-6
references.pmid: 5160711
references.citation: Anesth Analg. 1994 May;78(5):1000-21
references.pmid: 8160966
references.citation: Methods Enzymol. 1985;112:195-203
references.pmid: 4046849